RSS0309
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 23, 2025
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Recruiting | Sponsor: Reistone Biopharma Company Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
September 06, 2025
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Not yet recruiting | Sponsor: Reistone Biopharma Company Limited
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 2
Of
2
Go to page
1